Life sciences lawyers, solicitors and barristers at Keystone Law

The healthcare and life sciences industry is constantly changing and developing. Advisors with sector-specific expertise are essential to ensure opportunities are not missed whilst risk is kept to a minimum.

Our services

Our team of healthcare lawyers and life sciences lawyers regularly advise clients on issues such as mergers and acquisitions, joint ventures, capital investment projects, Bribery Act compliance, competition law, biotech/drug development and commercial agreements. We also advise on a wide range of day-to-day matters, including employment and pensions, procurement, disputes, health & safety, general commercial matters and real estate transactions.

Who do we advise?

Our healthcare and life sciences clients are predominantly research institutes, funding bodies, life sciences companies and organisations from the public sector.

The team works with senior management and in-house legal departments to deliver comprehensive and pragmatic advice.

Why choose our healthcare and life sciences team?

Keystone’s healthcare and life sciences team comprises specialist solicitors, valued for their ability to deliver innovative and cost-effective solutions within this important sector. Our highly experienced healthcare and life sciences specialists are experts in this field, and have been recognised in leading legal directories Chambers UK and The Legal 500.

For further information or to discuss a healthcare and life sciences matter, please telephone 020 3319 3700 or click here to email us.

To receive our monthly email newsletter, please click here.

Back to search

Keynote

Contract liability caps: what can we learn from the Portsmouth University case?

Vicky Clark

8 July 2024

News

Five Keystone Law lawyers listed as Thomson Reuters Stand-out Lawyers 2024

View all Keynotes
View all News

Commercial services (including intellectual property)

Clinical trial agreements
Consultancy agreements
Distribution agreements
Health and Safety
Manufacture of healthcare products
Material transfer agreements
Protection and exploitation of intellectual property
Research and development agreements
Research grant terms
Technology assignments
Technology licensing
Terms and conditions of sale and service

Corporate services (including competition/anti-trust)

Anti-trust/competition issues
Banking and finance
Company formation/company secretarial
Companies Act regulation
Director’s’ duties
Equity and convertible equity finance
Factoring and invoice discounting
Joint ventures
Mergers and Acquisitions
Non-disclosure agreements/confidentiality agreements
Shareholder agreements

View all Sectors

Advised on regulations relevant to new pharmaceutical products
Advised a consumer health SME based in Scotland on licensing arrangements for a new health supplement with a European headquartered pharma company which specialises in over-the-counter and generic drugs
Advised a drug-discovery and development-services company on a collaboration agreement with a global company that produces speciality chemicals that are used in some of the biggest, most successful brands in the world
Advised a US-based medical device developer on IP due diligence matters, patent assignments and ongoing joint venture and collaboration agreements in the UK, US and Asia
Advised Cancer Research UK on the negotiation of (i) a patent and know-how licence to Tusk Therapeutics Limited, an immune-oncology company, and (ii) a related tripartite research collaboration agreement which also involved University College London
Advised a pharmaceutical company in relation to a dispute with another pharmaceutical company in relation to royalty payments and other losses under a pharmaceutical licensing agreement pertaining to a product, the trade mark for which was owned by them
Advised a large orthopaedic company on a new scheme for compensating inventors, some of which were orthopaedic surgeons, creating new medical devices (replacement hips, knees, etc.) for them involving share options
Advised a drug development company on its new project to develop cellular-based diagnostic systems for natural products
Advised a biotechnology company on the assignment of all rights in a cell line going to them and a licence to the related antibody
Advised the CEO of pharmaceutical company on the renegotiation of his agreement with a research-based pharmaceutical company under which they were the exclusive distributor of certain products of theirs in Greece and Cyprus
Developed a model distribution agreement for the distribution of a leading company that specialises in wound-healing medical devices
Advised a cancer specialist company in relation to its distribution agreement with a research and development company relating to its new cancer diagnostic kit
Advised a global pharmaceutical contract development company on its pharmaceutical manufacturing agreement with a biopharmaceutical company that develops transformative solutions for patients and in particular on issues relating to the sub-licence of technology from a university and how to address risks related thereto
Advised a pharmaceutical supplier on the commercial terms of its settlement of litigation with global pharmaceutical company focused on developing, manufacturing and commercialising branded pharmaceuticals
Advised a biosciences company on the exploitation of the UK Patent Box legislation and drafting and advising on commercial agreements required to take advantage of the Patent Box
Advised a leading contract development and manufacturing organisation on a potential dispute relating to ownership of intellectual property (including patents) arising from research and development work conducted by it in relation to a third-party novel pain medication
Advised a small pharmaceutical company in relation to a dispute with a larger pharmaceutical company in relation to royalty payments under a pharmaceutical licensing agreement
Formed and developed a new legal department for a substantial FTSE 250 drug delivery company, including acting as general counsel on an interim basis. Managed the development of new commercial, regulatory and compliance procedures

Please note: The experience list above features work carried out by lawyers who now work at Keystone Law however this work may have been completed prior to them joining the firm.